SCM
MDGL icon

Stevens Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Stevens Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,547
Closed -$545K – 824
2018
Q3 		$545K Buy
2,547
+1,721
+208% +$432K 0.02% 516
2018
Q2 		$231K Buy
+826
New +$145K 0.01% 674
2015
Q3 		– Sell
-450
Closed -$35K – 1126
2015
Q2 		$35K Sell
450
-795
-64% -$66.7K ﹤0.01% 975
2015
Q1 		$85K Sell
1,245
-559
-31% -$47.9K ﹤0.01% 930
2014
Q4 		$167K Sell
1,804
-480
-21% -$49.6K 0.01% 883
2014
Q3 		$241K Sell
2,284
-171
-7% -$23.8K 0.01% 801
2014
Q2 		$351K Buy
2,455
+2,149
+702% +$314K 0.01% 766
2014
Q1 		$46K Sell
306
-174
-36% -$34.3K ﹤0.01% 1034
2013
Q4 		$88K Buy
480
+177
+58% +$32.4K ﹤0.01% 970
2013
Q3 		$67K Buy
+303
New +$64.5K ﹤0.01% 982

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return